Home About Science Investors & Partners Our people News & Events Careers Contact us Listen to our CEO and CSO talk at the Northland Synthetic Lethality Conference – Nov 17 2021 December 2, 2021 Conferences Listen to our CEO Dr Niall Martin and our CSO, Dr Graeme Smith talking about Synthetic Lethality; they participated on two panel discussions focusing on Synthetic Lethality and 2022 trends and PARP Inhibitors at the Northland Synthetic Lethality Conference – Nov.17th 2021 Click on the link and add your name, company and email address to access the panel talks 930am ET panel – Roundtable discussion with CEOs from Four Biotech Companies (Repare, IDEAYA. Artios, Impact) https://www.webcaster4.com/Webcast/Page/2816/43644 Noon ET panel – PARP Inhibitors / private Co. showcase (Artios / Atrin / Impact) https://www.webcaster4.com/Webcast/Page/2816/43646 Contact us Reach out to us. View our Careers Related Articles Listen to our CEO and CSO talk at the Northland Synthetic Lethality Conference – Nov 17 2021 CONFERENCES Artios Appoints Nora Brennan to Board of Directors and Audit Committee Chair PRESS RELEASE Quick links Home About Science Our team News & events Contact us Contact Telephone: +44 (0)1223 867 900 General enquiries: info@artiospharma.com Careers: HR@artiospharma.com Finance: Accounts@artiospharma.com Our career opportunities Our careers © Artios Pharma 2019 Terms & conditions | Privacy policy | Site map We use cookies to collect data, please see our privacy policy.

Home About Science Investors & Partners Our people News & Events Careers Contact us Our people THE ARTIOS TEAM Our experienced leadership team is led by Niall Martin, CEO, who played a key role in identifying Lynparza™ (olaparib) and other DDR inhibitors. He is supported by a scientific research and development team with vast experience in DDR and drug discovery. 7 Leadership Board Scientific advisors Clinical advisors Niall Martin Chief Executive Officer Abid Ansari Chief Financial Officer Bryony Harrop VP of Clinical Development Simon Boulton VP of Scientific Strategy Tania Dimitrova Chief Business Officer Gillian Langford VP of Clinical Development Andrew Muncey Chief Operating Officer and Company Secretary Graeme Smith Chief Scientific Officer Ian Smith Chief Medical Officer Quick links Home About Science Our team News & events Contact us Contact Telephone: +44 (0)1223 867 900 General enquiries: info@artiospharma.com Careers: HR@artiospharma.com Finance: Accounts@artiospharma.com Our career opportunities Our careers © Artios Pharma 2019 Terms & conditions | Privacy policy | Site map We use cookies to collect data, please see our privacy policy.